GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Intrinsic Value: Projected FCF

Visioneering Technologies (ASX:VTI) Intrinsic Value: Projected FCF : A$0.00 (As of May. 16, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-16), Visioneering Technologies's Intrinsic Value: Projected FCF is A$0.00. The stock price of Visioneering Technologies is A$0.105. Therefore, Visioneering Technologies's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Visioneering Technologies's Intrinsic Value: Projected FCF or its related term are showing as below:

ASX:VTI's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.78
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Visioneering Technologies Intrinsic Value: Projected FCF Historical Data

The historical data trend for Visioneering Technologies's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Intrinsic Value: Projected FCF Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Visioneering Technologies's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Visioneering Technologies's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Price-to-Projected-FCF falls into.



Visioneering Technologies Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Visioneering Technologies  (ASX:VTI) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Visioneering Technologies's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.105/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visioneering Technologies Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies (ASX:VTI) Business Description

Traded in Other Exchanges
N/A
Address
10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.

Visioneering Technologies (ASX:VTI) Headlines

From GuruFocus

Top 5 4th Quarter Trades of Spectrum Planning & Advisory Services Inc.

By GuruFocus Research GuruFocus Editor 01-20-2023

Top 5 3rd Quarter Trades of Patriot Investment Management Inc.

By GuruFocus Research GuruFocus Editor 11-03-2022

PrairieView Partners, LLC Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-31-2023

Top 5 4th Quarter Trades of Novo Holdings A/S

By GuruFocus Research GuruFocus Editor 02-18-2023

Top 5 4th Quarter Trades of H&H Retirement Design & Management INC

By GuruFocus Research GuruFocus Editor 01-17-2023

Top 5 4th Quarter Trades of Peterson Wealth Advisors, LLC

By GuruFocus Research GuruFocus Editor 01-21-2023

GP Brinson Investments LLC Buys 4, Sells 1 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-06-2023

McClarren Financial Advisors, Inc.'s Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-01-2022

McClarren Financial Advisors, Inc. Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-31-2023

CONTINENTAL INVESTORS SERVICES, INC. Buys 2, Sells 3 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 12-15-2022